Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Author Correction: Development...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Author Correction: Development of a proteomic signature associated with severe disease for patients with COVID-19 using data from 5 multicenter, randomized, controlled, and prospective studies

Author Correction: Development of a proteomic signature associated with severe disease for patients with COVID-19 using data from 5 multicenter, randomized, controlled, and prospective studies

Bibliographic Details
Main Authors: Sandra Castro-Pearson, Sarah Samorodnitsky, Kaifeng Yang, Sahar Lotfi-Emran, Nicholas E. Ingraham, Carolyn Bramante, Emma K. Jones, Sarah Greising, Meng Yu, Brian T. Steffen, Julia Svensson, Eric Åhlberg, Björn Österberg, David Wacker, Weihua Guan, Michael Puskarich, Anna Smed-Sörensen, Elizabeth Lusczek, Sandra E. Safo, Christopher J. Tignanelli
Format: Article
Language:English
Published: Nature Portfolio 2024-07-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-024-67607-4
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

https://doi.org/10.1038/s41598-024-67607-4

Similar Items

  • Development of a proteomic signature associated with severe disease for patients with COVID-19 using data from 5 multicenter, randomized, controlled, and prospective studies
    by: Sandra Castro-Pearson, et al.
    Published: (2023-11-01)
  • Developing A Baseline Metabolomic Signature Associated with COVID-19 Severity: Insights from Prospective Trials Encompassing 13 U.S. Centers
    by: Kaifeng Yang, et al.
    Published: (2023-10-01)
  • 68 Metformin prevents the diagnosis of Long Covid in phase 3 trial of early treatment.
    by: Carolyn Bramante, et al.
    Published: (2023-04-01)
  • Metformin and Covid-19: Focused Review of Mechanisms and Current Literature Suggesting Benefit
    by: Sherehan Ibrahim, et al.
    Published: (2021-07-01)
  • 79885 Self-Weighing in Adolescents with Obesity: Attitudes of Teens and their Parents.
    by: Carolyn Bramante
    Published: (2021-03-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs